← Back to Patent Explorer
US4296233A Expired / Lapsed US ⏱️ 0.0 years remaining

Conjugate of amino sugar-steroid hormone

Assignee: Kureha Corp
•
Filing: 1979-03-29
•
Granted: 1981-10-20
•
Expires: 1999-03-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Conjugates of amino sugar-steroid hormone are prepared by binding an amino sugar to steroid hormone at 3- or 17-position by a direct reaction or by binding with a binding agent, and the conjugate is useful in an enzyme immunoassay method.

Inventors

  • 👤 Satoru Enomoto
  • 👤 Kiro Asano
  • 👤 Hiromitsu Tanaka

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 01:36
CPC Classifications
C; C07; C07J; C07J41/00; C07J41/0033; C07J41/0088; C07J1/00; C07J1/0003; C07J1/0011; C07J1/0051; C07J1/0066; C07J1/007; C07J1/0074; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/743; Y; Y10; Y10S; Y10S435/00; Y10S435/962; Y10S436/00; Y10S436/815; Y10S436/817

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 115 words
A conjugate of an amino sugar and a steroid hormone having the formula: ##STR6## wherein R 1 C is a radical of a carboxyl group containing amino sugar selected from the group consisting of 2-amino-2-deoxy-glucuronic acid, 2-amino-2-deoxy-3-O-(1-carboxyethyl) D-glucose and 2-amino-2-deoxy-3-O-β-D-glucopyranurosyl-D-galactose; R 2 is a radical of a steroid hormone selected from the group consisting of 17β-hydroxy-4-androsten-3-one; 3β-hydroxy-5-androsten-17-one; 1,3,5 (10)-estratriene-3,17 β-diol; 5β-pregnane-3α, 20α-diol; 4-pregnene-3, 20-dione; 11β, 17α, 21-trihydroxy-4-pregnene-3, 20-dione; 11β, 21-dihydroxy-4-pregnene-3,20-dione; prednisone; desoxymethasone, mestanolone; androstanolone; unsodeoxycholic acid methanedienone; β-sitosterol and Alphaxalone, the bonding between said amino sugar radical and said steroid hormone radical occurring only at the 3 or 17 position of said steroid radical; m is 0 or 1 and n is 1 or 2.
Claim 2
Dependent Claim 115 words
A conjugate of an amino sugar and a steroid hormone having the formula: ##STR6## wherein R 1 C is a radical of a carboxyl group containing amino sugar selected from the group consisting of 2-amino-2-deoxy-glucuronic acid, 2-amino-2-deoxy-3-O-(1-carboxyethyl) D-glucose and 2-amino-2-deoxy-3-O-β-D-glucopyranurosyl-D-galactose; R 2 is a radical of a steroid hormone selected from the group consisting of 17β-hydroxy-4-androsten-3-one; 3β-hydroxy-5-androsten-17-one; 1,3,5 (10)-estratriene-3,17 β-diol; 5β-pregnane-3α, 20α-diol; 4-pregnene-3, 20-dione; 11β, 17α, 21-trihydroxy-4-pregnene-3, 20-dione; 11β, 21-dihydroxy-4-pregnene-3,20-dione; prednisone; desoxymethasone, mestanolone; androstanolone; unsodeoxycholic acid methanedienone; β-sitosterol and Alphaxalone, the bonding between said amino sugar radical and said steroid hormone radical occurring only at the 3 or 17 position of said steroid radical; m is 0 or 1 and n is 1 or 2.
Claim 3
Dependent Claim 44 words
A process for producing the amino sugar-steroid hormone conjugate of claim 1, comprising: reacting a carboxyl group containing amino sugar with a steroid hormone, said reaction occurring between the carboxyl group of said amino sugar and the 3- or 17-position of said steroid hormone.
Claim 4
Dependent Claim 20 words
The process of claim 2, wherein said carboxyl group containing amino sugar is in the form of its silver salt.
Claim 5
Dependent Claim 71 words
A process for producing the amino sugar-steroid hormone conjugate of claim 1, comprising; reacting a carboxyl group containing amino sugar with said steroid hormone at the 3- or 17-position of said steroid hormone in the presence of a binding agent, said binding agent being selected from the group consisting of: X(CH.sub.2).sub.n COOH, X(CH.sub.2).sub.n COX, HOOC(CH.sub.2).sub.n COOH, and XOC(CH.sub.2).sub.n COX wherein n is 1 or 2 and X is a halogen atom.
Claim 6
Dependent Claim 10 words
The process of claim 4, wherein said conjugate is acetylized.

References Cited (Backward Citations)

US3427300A Cited
US3678029A Cited
US3836520A Cited
US4003998A Cited
US3963697A Cited
US4021535A Cited
US4088757A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-10-19 1985-04-20 1985-10-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-10-19 1989-04-20 1989-10-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-10-19 1993-04-20 1993-10-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag